2/4
02:04 pm
rhhby
Roche (OTCMKTS:RHHBY) had its "underweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
Roche (OTCMKTS:RHHBY) had its "underweight" rating reaffirmed by analysts at Morgan Stanley.
2/4
08:00 am
rhhby
Genentech Awards Grant to Support Science Center's Translation Project
Low
Report
Genentech Awards Grant to Support Science Center's Translation Project
2/3
06:46 am
rhhby
SanegeneBio and Genentech sign $1.5bn global RNAi licensing deal [Yahoo! Finance]
Low
Report
SanegeneBio and Genentech sign $1.5bn global RNAi licensing deal [Yahoo! Finance]
2/3
04:13 am
rhhby
Pharmaceutical Contract Development and Manufacturing Organization Forecasts Report 2026: A $374.68 Billion Market by 2031 - One-Stop CDMOs, Rapid AI Platforms, and GLP-1/HPAPI Build-Outs Drive Demand [Yahoo! Finance]
Low
Report
Pharmaceutical Contract Development and Manufacturing Organization Forecasts Report 2026: A $374.68 Billion Market by 2031 - One-Stop CDMOs, Rapid AI Platforms, and GLP-1/HPAPI Build-Outs Drive Demand [Yahoo! Finance]
2/2
04:19 pm
rhhby
Genentech in up to $1.7B RNAi licensing deal with SanegeneBio [Seeking Alpha]
Low
Report
Genentech in up to $1.7B RNAi licensing deal with SanegeneBio [Seeking Alpha]
2/2
03:33 pm
rhhby
North Carolina is State of the Year, business magazine says [Yahoo! Finance]
Low
Report
North Carolina is State of the Year, business magazine says [Yahoo! Finance]
2/2
10:19 am
rhhby
ACROBiosystems Powers Innovation at bioSeedin's JPM Spotlight, Strategically Supporting Global Partnership Forging [Yahoo! Finance]
Low
Report
ACROBiosystems Powers Innovation at bioSeedin's JPM Spotlight, Strategically Supporting Global Partnership Forging [Yahoo! Finance]
2/2
07:29 am
rhhby
SanegeneBio Announces RNAi Global Licensing Collaboration with Genentech [Yahoo! Finance]
Low
Report
SanegeneBio Announces RNAi Global Licensing Collaboration with Genentech [Yahoo! Finance]
2/2
06:16 am
rhhby
Natera Submits Signatera™ CDx PMA to FDA [Yahoo! Finance]
Low
Report
Natera Submits Signatera™ CDx PMA to FDA [Yahoo! Finance]
1/31
09:32 pm
rhhby
Roche's CT-388 Obesity Data Tests New Growth Pillar Potential [Yahoo! Finance]
Low
Report
Roche's CT-388 Obesity Data Tests New Growth Pillar Potential [Yahoo! Finance]
1/30
07:16 am
rhhby
Diagnostic Enzymes Research Report 2026 - Global $8.72 Bn Market Trends, Opportunities, and Forecasts to 2031 [Yahoo! Finance]
Low
Report
Diagnostic Enzymes Research Report 2026 - Global $8.72 Bn Market Trends, Opportunities, and Forecasts to 2031 [Yahoo! Finance]
1/29
08:28 pm
rhhby
Roche Holding AG (RHHBY) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Roche Holding AG (RHHBY) Q4 2025 Earnings Call Transcript [Seeking Alpha]
1/29
11:50 am
rhhby
Roche's Full-Year Earnings: Solid, No Alarms - Obesity Promise Makes The Buy Case [Seeking Alpha]
Low
Report
Roche's Full-Year Earnings: Solid, No Alarms - Obesity Promise Makes The Buy Case [Seeking Alpha]
1/29
01:39 am
rhhby
Roche Holding Non-GAAP EPS of CHF 19.46, revenue of CHF 61.52B; issues FY26 outlook [Seeking Alpha]
Medium
Report
Roche Holding Non-GAAP EPS of CHF 19.46, revenue of CHF 61.52B; issues FY26 outlook [Seeking Alpha]
1/28
09:57 am
rhhby
Neatly Health Launches Free AI Health Companion App, Transforming the Patient Experience [Yahoo! Finance]
Low
Report
Neatly Health Launches Free AI Health Companion App, Transforming the Patient Experience [Yahoo! Finance]
1/28
09:05 am
rhhby
Roche's CT-388 Adds Optionality In The GLP Market, But Wait For Dips [Seeking Alpha]
Low
Report
Roche's CT-388 Adds Optionality In The GLP Market, But Wait For Dips [Seeking Alpha]
1/28
04:01 am
rhhby
Roche Is The 'Value Play' Of The 2026 Obesity Gold Rush [Seeking Alpha]
Medium
Report
Roche Is The 'Value Play' Of The 2026 Obesity Gold Rush [Seeking Alpha]
1/27
08:33 am
rhhby
Is Roche Holding (SWX:ROG) Price Still Attractive After Strong One Year Share Performance [Yahoo! Finance]
Low
Report
Is Roche Holding (SWX:ROG) Price Still Attractive After Strong One Year Share Performance [Yahoo! Finance]
1/27
05:12 am
rhhby
Roche (OTCMKTS:RHHBY) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock.
Low
Report
Roche (OTCMKTS:RHHBY) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock.
1/27
04:36 am
rhhby
Genentech Announces Positive Phase II Results for Its Dual GLP-1/GIP Receptor Agonist CT-388 in People Living With Obesity [Yahoo! Finance]
Low
Report
Genentech Announces Positive Phase II Results for Its Dual GLP-1/GIP Receptor Agonist CT-388 in People Living With Obesity [Yahoo! Finance]
1/27
01:10 am
rhhby
Genentech Announces Positive Phase II Results for Its Dual GLP-1/GIP Receptor Agonist CT-388 in People Living With Obesity
Low
Report
Genentech Announces Positive Phase II Results for Its Dual GLP-1/GIP Receptor Agonist CT-388 in People Living With Obesity
1/26
08:18 am
rhhby
Frazier Life Sciences Appoints Charles Fuchs as Senior Advisor [Yahoo! Finance]
Low
Report
Frazier Life Sciences Appoints Charles Fuchs as Senior Advisor [Yahoo! Finance]
1/26
07:27 am
rhhby
Divamics Showcases Lead Autoimmune Program DVI-001 and Unveils New Metabolic Program DVI-004 at JPM Week 2026 [Yahoo! Finance]
Low
Report
Divamics Showcases Lead Autoimmune Program DVI-001 and Unveils New Metabolic Program DVI-004 at JPM Week 2026 [Yahoo! Finance]
1/24
03:28 pm
rhhby
Assessing Zealand Pharma (CPSE:ZEAL) Valuation After Prolonged Share Price Weakness [Yahoo! Finance]
Low
Report
Assessing Zealand Pharma (CPSE:ZEAL) Valuation After Prolonged Share Price Weakness [Yahoo! Finance]
1/23
12:05 am
rhhby
Protara Therapeutics to Present Updated Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Unresponsive NMIBC Patients at the ASCO Genitourinary Cancers Symposium [Yahoo! Finance]
Low
Report
Protara Therapeutics to Present Updated Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Unresponsive NMIBC Patients at the ASCO Genitourinary Cancers Symposium [Yahoo! Finance]